The first detections of circulating vaccine-derived poliovirus type 2 (cVDPV2) for 2023 were reported to the GPEI last week. Two acute flaccid paralysis (AFP) cases with onset of paralysis in late May, plus an asymptomatic community contact from a camp for displaced persons, were recorded in Fafi district in the province of Garissa. The infections have been linked to virus strains collected in Banadir, Somalia. Other cVDPV2 reports were issued by Benin (two cases from Borgou and Littoral), the Central African Republic (three cases from RS4, RS6 and RS7 regions), and Niger (single case in Maradi). Read more
Advice for travellers
Poliomyelitis is a potentially serious viral illness that is spread through contact with infected faeces or saliva. The risk to travellers is generally low, however vaccination is recommended for travel to affected regions and is a requirement for travel to/from some countries. If at risk, adults should have a booster to the childhood series. More on polio.
Before you travel, call Travelvax Australia’s telephone advisory service on 1300 360 164 (toll-free from landlines) for country-specific advice and information. You can also make an appointment at your nearest Travelvax clinic to obtain vaccinations, medication to prevent or treat illness, and accessories for your journey.